6533b824fe1ef96bd12813dd
RESEARCH PRODUCT
Regorafenib for previously treated metastatic colorectal cancer (mCRC): results from 683 Italian patients treated in the open-label phase IIIB CONSIGN study
A. ZaniboniAndrea SpallanzaniT.l. LatianoFortunato CiardielloF. Di CostanzoA. RussoM. MoscoviciE. Van CutsemMaria BanziM. Di BartolomeoLisa SalvatoreAlberto SobreroM. BigliettoCarlo BaroneAntonella SantoroVittorina ZagonelAlessio AmatuStefano Cascinusubject
Oncologymedicine.medical_specialtybusiness.industryColorectal cancerHematologymedicine.diseasechemistry.chemical_compoundOncologychemistryInternal medicineRegorafenibMedicineOpen labelbusinessPreviously treatedyear | journal | country | edition | language |
---|---|---|---|---|
2015-10-01 | Annals of Oncology |